CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
VIBRANT focuses on developing superparamagnetic nanocontainers for non-invasive imaging and quantification of pancreatic β-cell mass in diabetes patients. This technology aims to enhance early diagnosis and treatment options for diabetes, addressing a critical health challenge in Europe.
Currently, around 30 million people in the enlarged Europe suffer from diabetes, with a prevalence of 7.5% in member states.
In recent years the emergence of type 2 diabetes in children and adolescents is a new and serious health challenge to the youth of Europe, their families and society.
By 2025, the number of people with diabetes is expected to rise to around 50 million in Europe, thus increasing prevalence to 10.9%.
This devastating disease is ranked among the leading causes of fatal cardio…
Centrum fur Angewandte Nanotechnologie (CAN) GmbH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, HAMBURG
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
Denmark, Bagsvaerd
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Sweden, Stockholm
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Belgium, Bruxelles / Brussel
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
